{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:26Z","timestamp":1790630426433,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation L\u00e9on Fr\u00e9d\u00e9ricq"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.talanta.2019.06.044","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T21:07:18Z","timestamp":1560200838000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis"],"prefix":"10.1016","volume":"204","author":[{"given":"Gwena\u00ebl","family":"Nys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Cobraiville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel G.","family":"Malaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"de Seny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Fillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.talanta.2019.06.044_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"Wells","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.talanta.2019.06.044_bib2","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1002\/art.21607","article-title":"Discovery of new rheumatoid arthritis biomarkers using the surface\u2010enhanced laser desorption\/ionization time\u2010of\u2010flight mass spectrometry ProteinChip approach","volume":"52","author":"De Seny","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.talanta.2019.06.044_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1373\/clinchem.2007.099549","article-title":"Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis","volume":"54","author":"De Seny","year":"2008","journal-title":"Clin. Chem."},{"issue":"17","key":"10.1016\/j.talanta.2019.06.044_bib4","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.talanta.2019.06.044_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.eururo.2009.08.014","article-title":"Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome","volume":"57","author":"Paret","year":"2010","journal-title":"Eur. Urol."},{"issue":"18","key":"10.1016\/j.talanta.2019.06.044_bib6","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1002\/pmic.201400382","article-title":"Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype\u2010specific PRM assays","volume":"15","author":"Kim","year":"2015","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.talanta.2019.06.044_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066769","article-title":"Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties","volume":"8","author":"de Seny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.talanta.2019.06.044_bib8","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0902941","article-title":"Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model","author":"Connolly","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.talanta.2019.06.044_bib9","first-page":"58","article-title":"Serum amyloid A in the assessment of early inflammatory arthritis","volume":"27","author":"Cunnane","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.talanta.2019.06.044_bib10","first-page":"2014","article-title":"Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis","author":"Targo\u0144ska-St\u0119pniak","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.talanta.2019.06.044_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bjc.6605129","article-title":"Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer","volume":"101","author":"Cocco","year":"2009","journal-title":"Br. J. Canc."},{"issue":"11","key":"10.1016\/j.talanta.2019.06.044_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1369\/jhc.2010.956821","article-title":"Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis","volume":"58","author":"Urieli-Shoval","year":"2010","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/j.talanta.2019.06.044_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2407-12-365","article-title":"Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Canc."},{"issue":"8","key":"10.1016\/j.talanta.2019.06.044_bib14","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/1097-0142(20011015)92:8<2072::AID-CNCR1547>3.0.CO;2-P","article-title":"Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma","volume":"92","author":"Kimura","year":"2001","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.talanta.2019.06.044_bib15","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.jprot.2012.01.018","article-title":"Large-scale isotype-specific quantification of Serum amyloid A 1\/2 by multiple reaction monitoring in crude sera","volume":"75","author":"Sung","year":"2012","journal-title":"J. Proteom."},{"issue":"1","key":"10.1016\/j.talanta.2019.06.044_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.1758","article-title":"Differential expression and response to anti\u2010TNF\u03b1 treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis","volume":"206","author":"De Rycke","year":"2005","journal-title":"J. Pathol.: J. Pathol. Soc. Great Britain Ireland"},{"issue":"3","key":"10.1016\/j.talanta.2019.06.044_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","article-title":"Myeloid\u2010related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular\u2010onset juvenile rheumatoid arthritis","volume":"43","author":"Frosch","year":"2000","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"issue":"3","key":"10.1016\/j.talanta.2019.06.044_bib18","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar1939","article-title":"The S100A8\/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis","volume":"8","author":"Sunahori","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.talanta.2019.06.044_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage\u2010associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.talanta.2019.06.044_bib20","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1039\/C5SC03287C","article-title":"Calcium-induced tetramerization and zinc chelation shield human calprotectin from degradation by host and bacterial extracellular proteases","volume":"7","author":"Stephan","year":"2016","journal-title":"Chem. Sci."},{"issue":"5","key":"10.1016\/j.talanta.2019.06.044_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000201267","article-title":"Immunohistochemical distribution and serum levels of the Ca2+-binding proteins MRP8, MRP14 and their heterodimeric form MRP8\/14 in Crohn's disease","volume":"56","author":"L\u00fcgering","year":"1995","journal-title":"Digestion"},{"key":"10.1016\/j.talanta.2019.06.044_bib22","article-title":"Myeloid related proteins S100A8\/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis","author":"van Lent","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.talanta.2019.06.044_bib23","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar2645","article-title":"Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis","volume":"11","author":"Chen","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"36","key":"10.1016\/j.talanta.2019.06.044_bib24","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.274.36.25291","article-title":"S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14","volume":"274","author":"Vogl","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.talanta.2019.06.044_bib25","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1021\/pr100656u","article-title":"A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin","volume":"9","author":"Kuzyk","year":"2010","journal-title":"J. Proteome Res."},{"issue":"26","key":"10.1016\/j.talanta.2019.06.044_bib26","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.febslet.2007.09.060","article-title":"The hetero\u2010oligomeric complex of the S100A8\/S100A9 protein is extremely protease resistant","volume":"581","author":"Nacken","year":"2007","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.talanta.2019.06.044_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061832","article-title":"Human S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimers","volume":"8","author":"Riva","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.talanta.2019.06.044_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/00365513.2017.1419371","article-title":"Calprotectin (S100A8\/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis","volume":"78","author":"Nordal","year":"2018","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"12","key":"10.1016\/j.talanta.2019.06.044_bib29","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/art.24316","article-title":"C\u2010reactive protein and systemic lupus erythematosus","volume":"59","author":"Gaitonde","year":"2008","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.talanta.2019.06.044_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/rheumatology\/kep452","article-title":"Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases","volume":"49","author":"Baillet","year":"2010","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.talanta.2019.06.044_bib31","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.27638","article-title":"The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age\u2010dependent manner","volume":"62","author":"Deane","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.talanta.2019.06.044_bib32","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.20720","article-title":"Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis","volume":"50","author":"Liao","year":"2004","journal-title":"Arthritis Rheum."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914019306691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914019306691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:27:55Z","timestamp":1758544075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914019306691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":32,"alternative-id":["S0039914019306691"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2019.06.044","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2019.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}